Literature DB >> 30262665

Protein phosphatase 5 and the tumor suppressor p53 down-regulate each other's activities in mice.

Jun Wang1, Tao Shen2, Wuqiang Zhu3, Longyu Dou4, Hao Gu4, Lingling Zhang4, Zhenyun Yang3, Hanying Chen3, Qi Zhou3, Edwin R Sánchez5, Loren J Field3, Lindsey D Mayo3, Zhongwen Xie6, Deyong Xiao7, Xia Lin2, Weinian Shou8, Weidong Yong9.   

Abstract

Protein phosphatase 5 (PP5), a serine/threonine phosphatase, has a wide range of biological functions and exhibits elevated expression in tumor cells. We previously reported that pp5-deficient mice have altered ataxia-telangiectasia mutated (ATM)-mediated signaling and function. However, this regulation was likely indirect, as ATM is not a known PP5 substrate. In the current study, we found that pp5-deficient mice are hypersensitive to genotoxic stress. This hypersensitivity was associated with the marked up-regulation of the tumor suppressor tumor protein p53 and its downstream targets cyclin-dependent kinase inhibitor 1A (p21), MDM2 proto-oncogene (MDM2), and phosphatase and tensin homolog (PTEN) in pp5-deficient tissues and cells. These observations suggested that PP5 plays a role in regulating p53 stability and function. Experiments conducted with p53 +/- pp5 +/- or p53 +/- pp5 -/- mice revealed that complete loss of PP5 reduces tumorigenesis in the p53 +/- mice. Biochemical analyses further revealed that PP5 directly interacts with and dephosphorylates p53 at multiple serine/threonine residues, resulting in inhibition of p53-mediated transcriptional activity. Interestingly, PP5 expression was significantly up-regulated in p53-deficient cells, and further analysis of pp5 promoter activity revealed that p53 strongly represses PP5 transcription. Our results suggest a reciprocal regulatory interplay between PP5 and p53, providing an important feedback mechanism for the cellular response to genotoxic stress.
© 2018 Wang et al.

Entities:  

Keywords:  cancer; cell stress; gene knockout; p53; posttranslational regulation; protein phosphatase 5; protein phosphorylation; protein serine/threonine phosphatase (PSP); transcriptional regulation; tumorigenesis

Mesh:

Substances:

Year:  2018        PMID: 30262665      PMCID: PMC6254348          DOI: 10.1074/jbc.RA118.004256

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  72 in total

1.  Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases.

Authors:  I Takenaka; F Morin; B R Seizinger; N Kley
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

2.  Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis.

Authors:  B C McKay; M Ljungman; A J Rainbow
Journal:  Oncogene       Date:  1998-08-06       Impact factor: 9.867

3.  USP49 negatively regulates tumorigenesis and chemoresistance through FKBP51-AKT signaling.

Authors:  Kuntian Luo; Yunhui Li; Yujiao Yin; Lei Li; Chenming Wu; Yuping Chen; Somaira Nowsheen; Qi Hu; Lizhi Zhang; Zhenkun Lou; Jian Yuan
Journal:  EMBO J       Date:  2017-03-31       Impact factor: 11.598

4.  Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21(WAF1/Cip1) and mediate growth arrest.

Authors:  Z Zuo; N M Dean; R E Honkanen
Journal:  J Biol Chem       Date:  1998-05-15       Impact factor: 5.157

5.  Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress.

Authors:  K Morita; M Saitoh; K Tobiume; H Matsuura; S Enomoto; H Nishitoh; H Ichijo
Journal:  EMBO J       Date:  2001-11-01       Impact factor: 11.598

6.  Protein serine/threonine phosphatase-1 dephosphorylates p53 at Ser-15 and Ser-37 to modulate its transcriptional and apoptotic activities.

Authors:  D W-C Li; J-P Liu; P C Schmid; R Schlosser; H Feng; W-B Liu; Q Yan; L Gong; S-M Sun; M Deng; Y Liu
Journal:  Oncogene       Date:  2006-05-18       Impact factor: 9.867

7.  Regulation of PTEN transcription by p53.

Authors:  V Stambolic; D MacPherson; D Sas; Y Lin; B Snow; Y Jang; S Benchimol; T W Mak
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

8.  Retention of wild-type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formation.

Authors:  S Venkatachalam; Y P Shi; S N Jones; H Vogel; A Bradley; D Pinkel; L A Donehower
Journal:  EMBO J       Date:  1998-08-17       Impact factor: 11.598

9.  Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis.

Authors:  Veerendra Munugalavadla; Emily C Sims; Jovencio Borneo; Rebecca J Chan; Reuben Kapur
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

10.  Fanconi anemia type C and p53 cooperate in apoptosis and tumorigenesis.

Authors:  Brian Freie; Xiaxin Li; Samantha L M Ciccone; Kathy Nawa; Scott Cooper; Catherine Vogelweid; Laurel Schantz; Laura S Haneline; Attilio Orazi; Hal E Broxmeyer; Suk-Hee Lee; D Wade Clapp
Journal:  Blood       Date:  2003-07-10       Impact factor: 22.113

View more
  2 in total

Review 1.  Structure and function of the co-chaperone protein phosphatase 5 in cancer.

Authors:  Rebecca A Sager; Natela Dushukyan; Mark Woodford; Mehdi Mollapour
Journal:  Cell Stress Chaperones       Date:  2020-04-02       Impact factor: 3.667

Review 2.  Cell Cycle and DNA Repair Regulation in the Damage Response: Protein Phosphatases Take Over the Reins.

Authors:  Adrián Campos; Andrés Clemente-Blanco
Journal:  Int J Mol Sci       Date:  2020-01-10       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.